PD-L1PBRM1-

Jieun Lee1, Seyoung Moon1, Hyun Jung Kwon2

  • 1Department of Pathology, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea.

Urologic oncology
|September 28, 2024
PubMed
概括

具有PBRM1变化的清细胞细胞癌 (ccRCC) 经常显示PD-L1表达,影响免疫治疗反应. PBRM1的改变可能会使PD-L1免疫组织化学 (IHC) 复杂化,作为ccRCC治疗的预测标志物.